SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950170-23-011398
Filing Date
2023-03-31
Accepted
2023-03-31 16:21:55
Documents
15
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A impl-20221231.htm   iXBRL 10-K/A 444362
2 EX-3.2 impl-ex3_2.htm EX-3 401735
3 EX-31.1 impl-ex31_1.htm EX-31 7602
4 EX-31.2 impl-ex31_2.htm EX-31 8069
  Complete submission text file 0000950170-23-011398.txt   1117171

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT impl-20221231_pre.xml EX-101.PRE 18329
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT impl-20221231_lab.xml EX-101.LAB 22449
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT impl-20221231.xsd EX-101.SCH 2643
9 EXTRACTED XBRL INSTANCE DOCUMENT impl-20221231_htm.xml XML 10099
Mailing Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119
Business Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119 206-568-1466
IMPEL PHARMACEUTICALS INC (Filer) CIK: 0001445499 (see all company filings)

IRS No.: 263058238 | State of Incorp.: DE | Fiscal Year End: 0426
Type: 10-K/A | Act: 34 | File No.: 001-40353 | Film No.: 23788074
SIC: 2834 Pharmaceutical Preparations